Last checked at 1 Feb 2024 07:01
1 February 2024
MicroSalt plc
("MicroSalt" or the "Company")
Notice of Presentation on Investor Meet Company
MicroSalt plc, (AIM: SALT) a company commercialising a patented technology to produce full-flavour, low-sodium salt for food manufacturers and consumers, is pleased to announce that following its admission to trading on AIM this morning, Rick Guiney (CEO) and Konrad Dabrowski (CFO) will hold a live presentation on the Company via the Investor Meet Company platform on 5 February 2024 at 4pm (UK local time).
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet MicroSalt plc via:
https://www.investormeetcompany.com/microsalt-plc/register
Investors who already follow MicroSalt plc on the Investor Meet Company platform will automatically be invited.
For more information, please visit www.microsaltinc.co, follow on twitter @microSaltPLC or contact:
MicroSalt plc | Via Flagstaff PR |
Rick Guiney, CEO | |
Zeus (Nominated Adviser and Broker) | +44 (0)20 3829 5000 |
David Foreman / James Edis (Investment Banking) | |
Dom King (Corporate Broking), Rupert Woolfenden (Sales) | |
Flagstaff PR (Financial PR) | +44 (0)20 7129 1474 |
Tim Thompson / Alison Allfrey / Anna Probert microsalt@flagstaffcomms.com |
Notes to Editors
MicroSalt® produces a patented full-flavour, low-sodium salt for food manufacturers and consumers.
MicroSalt is a major potential disruptor in the food market, thanks to its micron sized particles which deliver the same sense of saltiness to a wide range of foods but with approximately 50% less sodium. Excess sodium consumption is a significant contributor to cardiovascular disease and MicroSalt's solution meets the rising demand for healthier alternatives to traditional salt. The WHO has set a target for reducing global sodium intake by 30% by 2025, which it estimates will save 7 million lives by 2030.
Each year, cardiovascular disease costs the UK £19 billion - if the average salt intake was reduced by one gram per day, it has been estimated that 4,147 lives and £288 million would be saved each year in the UK. As a nation, the UK consumes 183 million kilograms of salt each year, and 70 per cent. of the typical person's sodium intake is hidden in processed foods.
Operational since 2018, MicroSalt uses a patent-protected technology which helps create high barriers to entry within the reduced-sodium salt market. The group has a US patent and 14 patent applications pending in other jurisdictions globally.
The Directors believe that MicroSalt is well positioned to capture growth in the low sodium market, which is expected to grow exponentially, and that there is also scope to enter the larger salt market.
MicroSalt has a three-pronged marketing strategy, targeting large B2B food manufacturers, the B2C market and e-commerce customers. Microsalt's all natural, low-sodium solution is well positioned to take advantage of the fast-growing market for a healthier alternative to traditional salt.
ENDS